Plasma donor centers are considered an “essential business,” because the plasma donated at our centers are used to manufacture life-saving medicines. These donations are more crucial than ever to ensure continued supply of these life-saving medicines.
We are taking new precautions within plasma centers to ensure a safe donation and
limit the spread of COVID-19. Grifols centers are following all guidance from local, state, and federal authorities developed to control the spread of COVID-19. For instance, we are utilizing more of an appointment system to limit the number of donors in our centers. We are seating donors in every-other donation bed and reduced the number of seats available in the lobby. We have enhanced existing cleaning protocols. We are carefully monitor both donor and employee temperatures before they come into a center.
We are proud that Grifols, our parent company, is leading the national response to the COVID-19 pandemic. Grifols has begun identifying, screening and selecting volunteer donors who have recovered from COVID-19 to donate their plasma. Our local Albany, GA facility is one of these donation centers.
The plasma will be used to produce a hyperimmune globulin that could potentially treat the disease
All potential donors must be prescreened. Those interested should visit GRIFOLSPLASMA.COM/EN/ENDCVI9 to find out more about the locations and protocols in place prior to visiting a Grifols plasma center
Here are some requirements to donate plasma:
- Interested recovered donors must have a diagnosis made with a test (nasal swab or
blood) and complete resolution of COVID-19 symptoms at least 28 days prior to donation;
- Or complete resolution of symptoms at least 14 days prior to donation along with a
negative molecular test for COVID-19;
- As well as meet our routine eligibility criteria for normal source plasma donation.
- A donor must feel healthy, weigh more than 110 pounds and be between the ages of 18 and 69 and live in the local area. Visit grifolsplasma.com for details regarding eligibility.